← Back to all presentations Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes October 13, 2026 Troy Wilson, Ph.D., J.D., Francis Burrows, Ph.D., Robert Spencer, Ph.D. Webcast View the corporate and clinical update ← Next-Generation Menin Inhibitor KO-7246 Regenerates βCell Mass in Diabetic Rodent and Human Islet Models
